JPRN-UMIN000030811已完成未知
ong term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS) - Follow up study of WJTOG0105
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 331
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
An Observational follow-up study to Protocol 018MedDRA version: 14.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2013-001526-26-LTMerck Sharp & Dohme Corp.,16,071
进行中（未招募）
1 期
An Observational follow-up study to Protocol 018MedDRA version: 16.0Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2013-001526-26-LVMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.16,071
进行中（未招募）
1 期
An Observational follow-up study to Protocol 018MedDRA version: 14.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2013-001526-26-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.16,071
进行中（未招募）
1 期
An Observational follow-up study to Protocol 018MedDRA version: 17.0Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2013-001526-26-DKMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.7,745
进行中（未招募）
1 期
An Observational follow-up study to Protocol 018OsteoporosisEUCTR2013-001526-26-PLMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.16,071